This is not a review, but it is an observation on how there’s often  something deeply revealing about how founders step back, I tend to be fascinated because in some cases its not a dramatic exit. Not the scandal-laced sell-offs. But the quiet, deliberate recalibrations, the kind that don’t scream for attention, yet signal everything.

That’s what we’re witnessing with Dis-Chem. At face value, the headlines are easy to misread: sons selling over R600 million in shares, a founder stepping down, leadership shifting.

It’s the kind of narrative that often gets flattened into a familiar trope, something must be wrong. But that reading says more about how we’ve been conditioned to interpret wealth and control than it does about what’s actually happening here.

Because this isn’t instability to me. Instead it looks like strategy.

In 2025, Ivan Saltzman (without PR Drama) transferred a significant portion of ownership, roughly a quarter of the business to his sons. A move that, in many ways, formalised what succession is supposed to look like but so rarely does: intentional, structured, and still firmly within the family’s orbit.

And then, almost immediately after, a portion of that stake is sold.

Not all of it. Not even close. Just enough. Enough to suggest something important: that the next generation isn’t simply inheriting wealth, they’re managing it.

This is where the nuance lives.
Because what looks like a sell-off is, in reality, a rebalancing. A recognition that concentration, even in a successful, legacy-defining business, is risk.

And that true stewardship sometimes means loosening your grip just enough to ensure longevity, not just of the company, but of the family’s broader financial ecosystem.

At the same time, control hasn’t disappeared. It hasn’t even meaningfully diluted. The Saltzman name remains structurally embedded in the business, even as day-to-day leadership shifts further toward professional management.

This is the part that often goes under-acknowledged in South African business storytelling: the evolution from founder-led to institution-led doesn’t have to come at the expense of legacy. It can, if done well, actually protect it.

Maybe Dis-Chem, quietly, seems to be attempting exactly that.
A founder steps down as CEO. Later, from executive duties. But not entirely. Not abruptly. There’s a lingering presence, not as control, but as continuity. A soft landing rather than a hard exit.
Meanwhile, the business continues to expand.

New stores. Digital investments. A future-facing posture that suggests confidence, not retreat.

So perhaps the more interesting question isn’t why are they selling?

It’s why do we still read strategic transitions as warning signs?
Maybe because we’re more familiar with stories of collapse than with stories of careful evolution. Maybe because generational wealth in the South African context still feels new enough to be scrutinised at every turn. Or maybe because we’re still learning how to recognise power when it moves quietly instead of loudly.

What’s happening here isn’t a family stepping away.
It’s a family repositioning, tightening where it matters, releasing where it’s smart, and, most importantly, designing a version of control that can outlive the founder.

And that, in its own understated way, might be the most sophisticated move of all. And mind you, if I’m wrong about these observations, I’ll be the first to eat saw-dust.